相关实验视频
Updated: Jul 27, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
在体内通过MDM2的小分子抗剂激活p53通路
Lyubomir T Vassilev1, Binh T Vu, Bradford Graves
1Department of Discovery Oncology, Roche Research Center, Hoffmann-La Roche, Inc., Nutley, NJ 07110, USA. lyubomir.vassilev@roche.com
概括
研究人员确定了抑制MDM2的小分子,这是瘤中过度表达的蛋白质. 这种抑制会重新激活p53瘤抑制剂,提供了一个有前途的新癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 人类瘤中MDM2蛋白过度表达是常见的,导致p53瘤抑制功能受损.
- MDM2负面调节p53的转录活性和稳定性,阻碍其瘤抑制作用.
- 准MDM2-p53相互作用为癌症治疗提供了潜在的治疗策略.
研究的目的:
- 为了识别和表征MDM2.的小分子抗剂.
- 阐明这些MDM2抑制剂的作用机制.
- 在临床前癌症模型中评估MDM2抑制的治疗潜力.
主要方法:
- 针对MDM2-p53结合接口的小分子抗剂的鉴定.
- 用X射线结晶学来确定MDM2抑制剂复合物的结构.
- 在体外和体内研究以评估p53通路激活和抗瘤疗效.
主要成果:
- 发现了MDM2的强效和选择性小分子抑制剂.
- 在MDM2.2.的p53结合口袋内结合化合物的结构确认.
- 证明了p53通路的激活,导致癌细胞中细胞亡和细胞循环停止.
- 在小鼠模型中显著抑制人类瘤异种移植生长.
结论:
- 小分子抑制MDM2是一种可行的癌症治疗策略.
- 这些新型抗体有效地重新激活p53通路,诱导抗瘤效应.
- 进一步开发MDM2抑制剂对瘤学中的临床应用具有前景.
相关概念视频
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

